MacroGenics (MGNX) Stock Analysis & AI Equity Report
MacroGenics (MGNX) overview
MacroGenics (MGNX) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 150m and operating profit of USD -72.8m; the year-end share price was 1.61 USD and market capitalisation was USD 102m. MacroGenics is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get MacroGenics's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
About MacroGenics
MacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapeutics for cancer. Its product candidates include antibody-drug conjugates and multispecific antibodies, developed using its antibody technology platforms. The company also collaborates with biopharmaceutical partners on product development and operates a commercial-scale antibody manufacturing facility, providing contract development and manufacturing services for clinical and commercial products.
Generate the MacroGenics report
MacroGenics is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for MacroGenics and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.
Analyst reports on MacroGenics
Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.